المؤلفون: Gaëlle Farge, Laurent Mortier, Stéphane Dalle, Olivier Dereure, Sheenu Chandwani, Caroline Dutriaux, Sophie Dalac, Laurie Levy-Bachelot, Laetitia Verdoni, Emilie Scherrer, Clara Allayous, Céleste Lebbé, Emilie Casarotto, B. Oriano

المساهمون: MSD France, Merck & Co. Inc, CHU Lille, Thérapies Laser Assistées par l'Image pour l'Oncologie - U 1189 (ONCO-THAI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Hôpital Saint-André, CHU Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)

المصدر: Immunotherapy
Immunotherapy, 2021, 13 (11), pp.905-916. ⟨10.2217/imt-2021-0077⟩

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Skin Neoplasms, Databases, Factual, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Immunology, Kaplan-Meier Estimate, Pembrolizumab, Antibodies, Monoclonal, Humanized, computer.software_genre, Tumor response, survival, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, cohort study, medicine, Overall survival, Humans, Immunology and Allergy, Stage (cooking), Immune Checkpoint Inhibitors, Melanoma, Aged, Advanced melanoma, Aged, 80 and over, Database, business.industry, Immunotherapy, Middle Aged, medicine.disease, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, immunotherapy, pembrolizumab, France, business, computer, Cohort study

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eeecf15ac2f76c4e915b9fc7920c053Test
https://doi.org/10.2217/imt-2021-0077Test

المؤلفون: Charles Lance Cowey, Emilie Scherrer, April Beeks, Clemens Krepler, Marley Boyd, Kathleen M. Aguilar

المصدر: Cancer Medicine, Vol 9, Iss 21, Pp 7863-7878 (2020)
Cancer Medicine

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Skin Neoplasms, Time Factors, Programmed Cell Death 1 Receptor, Medical Oncology, immunology, 0302 clinical medicine, Risk Factors, Medicine, Community Health Services, Molecular Targeted Therapy, Immune Checkpoint Inhibitors, Melanoma, Original Research, Community based, Aged, 80 and over, Middle Aged, MAP Kinase Kinase Kinases, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Progression-Free Survival, 030220 oncology & carcinogenesis, Female, Drug Utilization, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, First line, Risk Assessment, survival, lcsh:RC254-282, 03 medical and health sciences, Internal medicine, Humans, Radiology, Nuclear Medicine and imaging, Protein Kinase Inhibitors, Advanced melanoma, Aged, Retrospective Studies, Adult patients, business.industry, target therapy, Clinical Cancer Research, biomarkers, Retrospective cohort study, 030104 developmental biology, Propensity score matching, Mutation, Observational study, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96fc6bc46c16e1f918585ef9a89a846dTest
https://doaj.org/article/ee976dd75d584d12914c8df2bc5510e8Test

المؤلفون: Cathy A Pinto, Xinyue Liu, Xiaoyun Li, Emilie Scherrer, Mizuho Kalabis

المصدر: Immunotherapy. 14(4)

مصطلحات موضوعية: Male, Databases, Factual, Immunology, Programmed Cell Death 1 Receptor, Middle Aged, Survival Analysis, Cohort Studies, Treatment Outcome, Oncology, Disease Progression, Immunology and Allergy, Humans, Female, Immunotherapy, Melanoma, Aged, Retrospective Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bac074913462573af98a533bb5bbc2bdTest
https://pubmed.ncbi.nlm.nih.gov/34870445Test

المؤلفون: Arielle G. Bensimon, Wei Gao, Madeline Jenkins, Emilie Scherrer, James Signorovitch, Raquel Aguiar-Ibáñez, Zheng-Yi Zhou, Clemens Krepler, Jingshu Wang, Yan Song

المصدر: Clinical Drug Investigation

مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, medicine.medical_treatment, Cost-Benefit Analysis, Population, Ipilimumab, Pembrolizumab, 030204 cardiovascular system & hematology, Placebo, Antibodies, Monoclonal, Humanized, 030226 pharmacology & pharmacy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Pharmacology (medical), Original Research Article, Adverse effect, education, Melanoma, Neoplasm Staging, Trametinib, education.field_of_study, business.industry, Dabrafenib, General Medicine, Health Care Costs, Middle Aged, Female, Quality-Adjusted Life Years, business, Adjuvant, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc665ba8e733bfe3fa1a444a1858bd33Test
https://pubmed.ncbi.nlm.nih.gov/32418051Test

المؤلفون: Emilie Scherrer, Wanmei Ou, Eric D. Whitman, Clemens Krepler

المصدر: Future oncology (London, England). 16(20)

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, medicine, Humans, In patient, Melanoma, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Anti pd 1, Retrospective cohort study, General Medicine, Immunotherapy, Middle Aged, medicine.disease, 030104 developmental biology, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Cutaneous melanoma, Retreatment, Female, Outcomes research, business, Progressive disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ecb7e4b6384a254b88279aeefff942cTest
https://pubmed.ncbi.nlm.nih.gov/32410465Test

المؤلفون: Todd A. Lee, Frank Xiaoqing Liu, Alicia C. Shillington, Emilie Scherrer, Vaidehi Dave, Scott J. Diede, Richard W. Joseph, Qing Harshaw, Cynthia Macahilig

المصدر: Journal of medical economics. 23(2)

مصطلحات موضوعية: Oncology, Male, Skin Neoplasms, medicine.medical_treatment, Pembrolizumab, Comorbidity, Severity of Illness Index, 0302 clinical medicine, Antineoplastic Agents, Immunological, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Metastasis, Melanoma, Aged, 80 and over, 030503 health policy & services, Health Policy, Age Factors, Health Services, Middle Aged, Hospitalization, Nivolumab, 030220 oncology & carcinogenesis, Health Resources, Female, 0305 other medical science, Emergency Service, Hospital, medicine.drug, Adult, medicine.medical_specialty, Ipilimumab, Antibodies, Monoclonal, Humanized, Disease-Free Survival, 03 medical and health sciences, Sex Factors, Internal medicine, medicine, Humans, Advanced melanoma, Aged, Neoplasm Staging, Retrospective Studies, business.industry, Immunotherapy, Emergency department, medicine.disease, Regimen, Socioeconomic Factors, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea03f3e3d324c5e59f46dbc80ab03ca2Test
https://pubmed.ncbi.nlm.nih.gov/31750751Test